Collegium Pharmaceutical Inc (COLL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Collegium Pharmaceutical Inc (COLL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7281
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative products for treating patients suffering from pain. The company develops products based on its DETERx platform technology. DETERx offers extended-release drug delivery, while protecting against common methods of abuse and tampering. Its lead product, Xtampza ER is designed to provide adequate pain control. Collegium’s other products include Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy; and Nucynta for the management of acute pain severe enough to require an opioid analgesic. Collegium is headquartered in Canton, Massachusetts, the US.

Collegium Pharmaceutical Inc (COLL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Collegium Pharmaceutical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Collegium Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Collegium Pharmaceutical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Collegium Pharma Raises USD50 Million in Venture Financing 10
Collegium Pharma Raises US$4 Million In Venture Financing 12
Equity Offering 13
Collegium Pharma Raises USD92 Million in Pubic Offering of Shares 13
Collegium Pharma Raises USD55 Million in Public Offering of Shares 15
Collegium Pharma Raises USD80 Million in IPO 17
Collegium Pharma Raises USD8 Million in Private Placement of Series C Preferred Stock 19
Collegium Pharma Raises USD0.9 Million in Second Tranche of Private Placement of Series C Preferred Stock 20
Collegium Pharma Raises USD3 Million in First Tranche of Private Placement of Series C Preferred Stock 21
Collegium Pharmaceutical Inc – Key Competitors 22
Collegium Pharmaceutical Inc – Key Employees 23
Collegium Pharmaceutical Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: Collegium reports second quarter financial results and provides corporate update 25
May 09, 2018: Collegium Reports First Quarter Financial Results and Provides Corporate Update 2018 27
Mar 07, 2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017 29
Nov 08, 2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update 31
Aug 09, 2017: Collegium Reports Second Quarter Financial Results and Provides Corporate Update 33
May 10, 2017: Collegium Reports 2017 First Quarter Financial Results and Provides Corporate Update 35
Mar 09, 2017: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 36
Corporate Communications 37
Jul 10, 2018: Collegium Promotes Scott Dreyer To CCO 37
Jun 04, 2018: Collegium Promotes Joseph Ciaffoni To Chief Executive Officer 38
Mar 19, 2018: Collegium Appoints Shirley Kuhlmann As General Counsel 39
May 30, 2017: Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer 40
Apr 04, 2017: Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Collegium Pharmaceutical Inc, Medical Equipment, Key Facts, 2017 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Collegium Pharmaceutical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Collegium Pharmaceutical Inc, Deals By Market, 2012 to YTD 2018 8
Collegium Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Collegium Pharma Raises USD50 Million in Venture Financing 10
Collegium Pharma Raises US$4 Million In Venture Financing 12
Collegium Pharma Raises USD92 Million in Pubic Offering of Shares 13
Collegium Pharma Raises USD55 Million in Public Offering of Shares 15
Collegium Pharma Raises USD80 Million in IPO 17
Collegium Pharma Raises USD8 Million in Private Placement of Series C Preferred Stock 19
Collegium Pharma Raises USD0.9 Million in Second Tranche of Private Placement of Series C Preferred Stock 20
Collegium Pharma Raises USD3 Million in First Tranche of Private Placement of Series C Preferred Stock 21
Collegium Pharmaceutical Inc, Key Competitors 22
Collegium Pharmaceutical Inc, Key Employees 23
Collegium Pharmaceutical Inc, Subsidiaries 24

List of Figures
Collegium Pharmaceutical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Collegium Pharmaceutical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Collegium Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Collegium Pharmaceutical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Collegium Pharmaceutical Inc (COLL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nanosonics Ltd (NAN):企業の財務・戦略的SWOT分析
    Nanosonics Ltd (NAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Teollisuuden Voima Oyj:企業の戦略的SWOT分析
    Teollisuuden Voima Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • JG Summit Holdings Inc:戦略・SWOT・企業財務分析
    JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wistron Corporation:企業の戦略・SWOT・財務分析
    Wistron Corporation - Strategy, SWOT and Corporate Finance Report Summary Wistron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gokul Refoils & Solvent Ltd. (GOKUL):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd, is a biopharmaceutical company which focuses on the development of soloMER products for the treatment of auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical can …
  • The Emirates Group:企業の戦略・SWOT・財務分析
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SKY Network Television Limited (SKT):企業の財務・戦略的SWOT分析
    SKY Network Television Limited (SKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Origin Energy Ltd (ORG):企業の財務・戦略的SWOT分析
    Origin Energy Ltd (ORG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Concur Technologies, Inc.:企業の戦略的SWOT分析
    Concur Technologies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Viettel Group
    Viettel Group - Strategy, SWOT and Corporate Finance Report Summary Viettel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Country Club Hospitality & Holidays Ltd.
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Commercial Bank of Dubai PSC:企業の戦略・SWOT・財務情報
    Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Avantium NV (AVTX):企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Valentino Fashion Group S.p.A:企業の戦略・SWOT・財務情報
    Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report Summary Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Laboratory Corporation of America Holdings:企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務情報
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alliance Healthcare Services Inc (AIQ)-製薬・医療分野:企業M&A・提携分析
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • Glen Dimplex Group:企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆